These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 29274572)
21. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524 [No Abstract] [Full Text] [Related]
22. Predicting DPP-IV inhibitors with machine learning approaches. Cai J; Li C; Liu Z; Du J; Ye J; Gu Q; Xu J J Comput Aided Mol Des; 2017 Apr; 31(4):393-402. PubMed ID: 28155089 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors. Khalaf RA; Jarad HA; Al-Qirim T; Sabbah D Med Chem; 2021; 17(9):937-944. PubMed ID: 32940185 [TBL] [Abstract][Full Text] [Related]
24. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365 [TBL] [Abstract][Full Text] [Related]
25. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation. Xing J; Li Q; Zhang S; Liu H; Zhao L; Cheng H; Zhang Y; Zhou J; Zhang H Chem Biol Drug Des; 2014 Sep; 84(3):364-77. PubMed ID: 24674599 [TBL] [Abstract][Full Text] [Related]
26. Model Optimization and In Silico Analysis of Potential Dipeptidyl Peptidase IV Antagonists from GC-MS Identified Compounds in Iheagwam FN; Ogunlana OO; Chinedu SN Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775302 [TBL] [Abstract][Full Text] [Related]
27. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis. Khalaf RA; Masalha D; Sabbah D Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors. Sharma M; Gupta M; Singh D; Kumar M; Kaur P Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin. Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090 [TBL] [Abstract][Full Text] [Related]
30. Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors. Jiang YK J Mol Model; 2010 Jul; 16(7):1239-49. PubMed ID: 20069322 [TBL] [Abstract][Full Text] [Related]
31. Structure⁻Activity Relationship and Molecular Docking of Natural Product Library Reveal Chrysin as a Novel Dipeptidyl Peptidase-4 (DPP-4) Inhibitor: An Integrated In Silico and In Vitro Study. Kalhotra P; Chittepu VCSR; Osorio-Revilla G; Gallardo-Velázquez T Molecules; 2018 Jun; 23(6):. PubMed ID: 29882783 [TBL] [Abstract][Full Text] [Related]
32. Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones. Arabiyat S; Kasabri V; Al-Hiari Y; Al-Masri I; Alalawi S; Bustanji Y Asian Pac J Cancer Prev; 2019 Aug; 20(8):2503-2514. PubMed ID: 31450926 [TBL] [Abstract][Full Text] [Related]
33. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors. Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564 [TBL] [Abstract][Full Text] [Related]
34. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120 [TBL] [Abstract][Full Text] [Related]
35. Ephedrine as a lead compound for the development of new DPP-IV inhibitors. Ojeda-Montes MJ; Ardid-Ruiz A; Tomás-Hernández S; Gimeno A; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Garcia-Vallvé S; Pujadas G; Valls C Future Med Chem; 2017 Dec; 9(18):2129-2146. PubMed ID: 29172693 [TBL] [Abstract][Full Text] [Related]
36. Structural Dynamics of DPP-4 and Its Influence on the Projection of Bioactive Ligands. Pantaleão SQ; Philot EA; de Resende-Lara PT; Lima AN; Perahia D; Miteva MA; Scott AL; Honorio KM Molecules; 2018 Feb; 23(2):. PubMed ID: 29473857 [TBL] [Abstract][Full Text] [Related]
37. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors. Lu IL; Tsai KC; Chiang YK; Jiaang WT; Wu SH; Mahindroo N; Chien CH; Lee SJ; Chen X; Chao YS; Wu SY Eur J Med Chem; 2008 Aug; 43(8):1603-11. PubMed ID: 18207285 [TBL] [Abstract][Full Text] [Related]
38. Exploration of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Silkworm Pupae ( Luo F; Fu Y; Ma L; Dai H; Wang H; Chen H; Zhu H; Yu Y; Hou Y; Zhang Y J Agric Food Chem; 2022 Mar; 70(12):3862-3871. PubMed ID: 35230117 [TBL] [Abstract][Full Text] [Related]
39. Peptides Derived from Soy and Lupin Protein as Dipeptidyl-Peptidase IV Inhibitors: In Vitro Biochemical Screening and in Silico Molecular Modeling Study. Lammi C; Zanoni C; Arnoldi A; Vistoli G J Agric Food Chem; 2016 Dec; 64(51):9601-9606. PubMed ID: 27983830 [TBL] [Abstract][Full Text] [Related]
40. Navigating the chemical space of dipeptidyl peptidase-4 inhibitors. Shoombuatong W; Prachayasittikul V; Anuwongcharoen N; Songtawee N; Monnor T; Prachayasittikul S; Prachayasittikul V; Nantasenamat C Drug Des Devel Ther; 2015; 9():4515-49. PubMed ID: 26309399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]